Peters, C., Bruno, A., Rizzari, C., Brescianini, A., von Stackelberg, A., Linderkamp, C., Zeng, Y., Zugmaier, G. and Locatelli, F. (2025) “Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk, first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen”, Haematologica. Pavia, Italy, 110(1), pp. 234-238. doi: 10.3324/haematol.2024.285837.